Arovella Therapeutics Ltd (ALA.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 06-2020 | 06-2019 | 06-2018 | 06-2017 | 06-2016 | |
| Cash Flows From Operating Activities | |||||
| Operating Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -141 | -313 | -68 | -85 | -27 |
| Net Acquisitions | N/A | N/A | 1,584 | N/A | N/A |
| Purchase Of Investment | N/A | N/A | N/A | N/A | -647 |
| Purchase Sale Intangibles | -247 | -1,072 | -840 | -1,223 | -1,396 |
| Investing Cash Flow | $-388 | $-1,384 | $676 | $-1,307 | $-2,070 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 140 | 1,050 | 543 | 1,025 |
| Debt Repayment | N/A | -140 | -850 | -470 | -920 |
| Common Stock Issued | N/A | 8,095 | N/A | 1,500 | N/A |
| Common Stock Repurchased | N/A | N/A | N/A | -90 | -36 |
| Other Financing Activity | -64 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $-64 | $8,095 | $200 | $1,483 | $69 |
| Beginning Cash Position | 4,314 | 98 | 1,770 | 2,449 | 6,252 |
| End Cash Position | 977 | 4,314 | 98 | 1,770 | 2,449 |
| Net Cash Flow | $-3,336 | $4,215 | $-1,672 | $-679 | $-3,803 |
| Free Cash Flow | |||||
| Capital Expenditure | -388 | -1,384 | -908 | -1,307 | -1,445 |
| Free Cash Flow | -388 | -1,384 | -908 | -1,307 | -1,445 |